PCA
JNJ icon

PMV Capital Advisers’s Johnson & Johnson JNJ Stock Holding History

PMV Capital Advisers’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-375
Closed -$57.3K – 83
2025
Q2 		$57.3K Hold
375
– – 0.13% 42
2025
Q1 		$62.2K Hold
375
– – 0.15% 34
2024
Q4 		$54.2K Buy
+375
New +$58.1K 0.15% 39

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PMV Capital Advisers's JNJ Position: Q3 2025 in Review

PMV Capital Advisers sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 375 shares — an estimated $57.3K sold.

PMV Capital Advisers first reported a position in JNJ in Q4 2024 and held it in 3 quarters. The position peaked at $62.2K in Q1 2025. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • PMV Capital Advisers reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • PMV Capital Advisers sold 375 Johnson & Johnson shares in Q3 2025, an estimated $57.3K.
  • PMV Capital Advisers first reported a position in Johnson & Johnson in Q4 2024 and held it in 3 quarters.
  • PMV Capital Advisers's Johnson & Johnson position peaked at $62.2K in Q1 2025.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on PMV Capital Advisers's 13F filing for Q3 2025, filed 6 Oct 2025.